Reuters logo
BRIEF-Takeda, Roivant Sciences launch Myovant Sciences to develop therapeutics for women's health, prostate cancer
2016年6月6日 / 上午11点17分 / 1 年前

BRIEF-Takeda, Roivant Sciences launch Myovant Sciences to develop therapeutics for women's health, prostate cancer

June 6 (Reuters) - Takeda Pharmaceutical Co :

* Roivant Sciences and Takeda launch Myovant Sciences to develop therapeutics for women’s health and prostate cancer

* Lynn Seely named president & Chief Executive Officer of Myovant Sciences Inc Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below